Harbour BioMed and Otsuka Enter $670M+ Global Agreement Across Asia, US, and Europe to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology ...

June 23, 2025 | Monday | News
Ipsen’s Cabometyx® Receives Positive CHMP Opinion for Advanced Neuroendocrine Tumors

Ipsen  announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion...

June 23, 2025 | Monday | News
Symbiotic.blue Launches in the UK to Redesign Drug Discovery with Brain-Inspired AI

Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) pla...

June 20, 2025 | Friday | News
Synfini and O2nix Bio Partner to Accelerate Anti-Metastatic Cancer Drug Discovery Targeting FTSJ1

Combination of World Leading Epitranscriptomics and AI-Driven Automation Aims to Accelerate Development of Cancer Therapies That Halt Metastasis  &...

June 19, 2025 | Thursday | News
Neurona Therapeutics Doses First Patient in Bilateral MTLE Trial of Regenerative Cell Therapy NRTX-1001

First patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date - - Trial funded...

June 19, 2025 | Thursday | News
Bayer Submits US FDA Application for Gadoquatrane, a Low-Dose MRI Contrast Agent

FDA submission seeks approval for investigational gadolinium-based contrast agent (GBCA) gadoquatrane for contrast-enhanced magnetic resonance imagin...

June 18, 2025 | Wednesday | News
Medicovestor Receives FDA Orphan Drug Designation for Pancreatic Cancer ADC

Medicovestor, Inc., a biotechnology company advancing next-generation antibody-drug conjugates (ADCs), announced that the U.S. Food and Drug Administrati...

June 18, 2025 | Wednesday | News
BioAro Launches PanOmiQ™ Research, Setting a New Standard for AI-Driven Multi-Omics and Drug Discovery

AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ™ Research sets a new global benchmark for prec...

June 17, 2025 | Tuesday | News
EMA Committee Backs Merck Animal Health’s NUMELVI as First Second-Generation JAK Inhibitor for Canine Allergic Dermatitis

If Approved, NUMELVI Will Be the First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Treatment of Pruritus Associated with Allergic D...

June 13, 2025 | Friday | News
Angelini Ventures Invests in Elkedonia to Advance First-in-Class Neuroplastogen for Treatment-Resistant Depression

Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existi...

June 12, 2025 | Thursday | News
EDETEK Partners with Capgemini to Accelerate AI-Driven Digital Transformation in Clinical Development

  EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advan...

June 11, 2025 | Wednesday | News
Yoneda Labs and Symeres Boost Cross-Coupling Reaction Yields from 30 to Over 90 Percent Using AI-Driven Optimization

Yoneda Labs, a leader in computational tools for reaction optimization, has successfully collaborated with Symeres, a leading transatlantic, small molecule...

June 10, 2025 | Tuesday | News
European Commission Approves Italfarmaco’s Duvyzat for Duchenne Muscular Dystrophy in Ambulatory Patients

Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an ...

June 09, 2025 | Monday | News
ByteBrain Launches MEDRAIL to Transform Clinical Trials with AI-Powered Compliance and Safety Automation

ByteBrain LLC, an emerging AI research and consulting firm, has announced the launch of MEDRAIL, an intelligent platform designed to help pharmaceutical co...

June 06, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close